On a population level, heart failure (HF) is associated with a 5-year mortality risk of 50%; this equals many types of cancer. However, lower mortality rates have been observed in recent trials. This may be explained by an improvement in medical treatment, patient education, and implantation of devices .
Insights into the risk of different HF outcomes stratified according to age is necessary to guide the patients appropriately, as well as to organise public HF care programmes. A Danish study, presented by Dr Christian Madelaire (University of Copenhagen Herlev Hospital, Denmark), examined the long-term mortality risk and risk of inpatient and outpatient worsening HF for patients ≤70 years with incident HF without severe comorbidity, initiating evidence-based medical therapy in a nationwide cohort.
From administrative registers, 19,985 HF patients aged ≤70 years with incident HF from 2000-2012 without severe comorbidity were identified. They had s...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Early discharge and home treatment feasible for low-risk pulmonary embolism patients Next Article
Treatment patterns PAH have changed recently »
Table of Contents: ACC 2019
Acute and Stable Ischaemic Heart Disease
Arrhythmias and Clinical Electrophysiology
Congenital Heart Disease
Heart Failure and Cardiomyopathies
Pulmonary Arterial Hypertension and Venous Thromboembolism
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.